South Australia has announced a partnership with the international biotech enterprise, BioCina, to become home to the first mRNA development and production facility in Australia and make homegrown mRNA vaccines a reality.
Last year, U.S. biotech giant Moderna and the Australian government agreed to build the first mRNA vaccine manufacturing facility outside North America.
Construction began on the Monash University campus in Victoria in Dec. 2022 and is expected to become operational in 2024.
While Victoria may be the most financially committed, South Australia—which already has a fully-operational laboratory for developing mRNA vaccines—may give Victoria a run for its money….